A randomized, double blind, placebo-controlled, phase 2a study of the efficacy, safety and pharmacokinetics of MLN3897 in patients with rheumatoid arthritis taking methotrexate.
Phase of Trial: Phase II
Latest Information Update: 07 Jan 2015
At a glance
- Drugs MLN 3897 (Primary) ; Methotrexate
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Millennium
- 01 Dec 2010 Results published in Arthritis and Rheumatism.
- 31 Jan 2010 Status changed from active, no longer recruiting to completed.
- 10 Dec 2009 Status changed from recruiting to active, no longer recruiting as reported by Netherlands Trial Register.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History